| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
2,241 |
2,131 |
$153K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
2,759 |
2,513 |
$149K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
1,646 |
1,625 |
$145K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
1,928 |
1,904 |
$121K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
1,193 |
1,077 |
$31K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
273 |
252 |
$8K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
636 |
331 |
$8K |
| 99000 |
|
2,406 |
2,183 |
$8K |
| 99058 |
|
114 |
112 |
$7K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
518 |
509 |
$6K |
| 87428 |
|
187 |
186 |
$4K |
| 81002 |
|
565 |
546 |
$1K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
38 |
37 |
$1K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
14 |
14 |
$1K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
32 |
31 |
$784.35 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
63 |
62 |
$472.64 |